Latest Innovation News

XPON Technologies has posted a strong H1 FY26 turnaround with a 58% revenue increase and a return to net profitability, driven by strategic acquisitions and operational improvements.

Radiopharm Theranostics has initiated dosing in its Phase 1/2a clinical trial of BetaBart, a novel radiotherapeutic developed with MD Anderson Cancer Center, targeting aggressive solid tumors.

The Agency Group Australia Ltd has reported a solid half-year performance with revenue rising 18% to $57.1 million and a 34% jump in gross commission income. The company narrowed its net loss and improved EBITDA, driven by strong sales and agent recruitment.

Calix Limited reported a solid 21% revenue increase for the half-year ending December 2025, but losses ballooned by 250%, raising questions about the path to profitability.

hipages Group Holdings Ltd has delivered a robust half-year performance, reporting 11% revenue growth and a significant jump in net profit to A$2.75 million for the period ending December 2025. The company’s strategic pricing changes and expansion in New Zealand underpin this strong momentum.

Lark Distilling Co. has reported a solid 10% increase in net sales revenue for the first half of FY26, driven by strong whisky sales and international expansion. The company is gearing up for a major global portfolio launch in the second half, backed by a refreshed brand and enhanced production capacity.

Singular Health Group reported a 55% rise in net loss to $2.97 million for H1 FY2026, driven by share-based payments and strategic hires, while making significant progress in US commercial deployments and securing FDA clearance for its cloud-based 3D medical imaging platform.

NZME Limited has reported a significant turnaround in 2025, posting a statutory net profit after tax of NZD 13.1 million and a 15% increase in operating EBITDA, underpinned by strong digital revenue growth across its divisions.

Steadfast Group announces the planned retirement of co-founder and CEO Robert Kelly AM, initiating a structured leadership transition with a new CEO expected by August 2026.

Apiam Animal Health has officially become a wholly owned subsidiary of Adamantem Capital's entities following a scheme of arrangement, with shareholders receiving a special dividend and a mix of cash and shares. The company will soon be delisted from the ASX.

Nickel Industries reported a reduced loss after tax of $41.2 million for 2025, underpinned by steady production and strategic progress on its ENC HPAL project and sustainability initiatives.

Aerometrex Limited has reported a robust half-year performance with record revenue growth and a dramatic increase in EBITDA, signalling strong operational momentum as it advances its SaaS transition.